domperidone has been researched along with Arrhythmias, Cardiac in 36 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Excerpt | Relevance | Reference |
---|---|---|
"We systematically searched MEDLINE, PubMed, EMBASE, Scopus and CINAHL Plus to identify observational studies examining the association of domperidone and sudden cardiac death and/or ventricular arrhythmia." | 9.12 | Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. ( Douros, A; Filion, KB; Moriello, C; Ou, LB, 2021) |
"The first author performed EMBASE, PubMed and Scopus searches to identify human studies assessing the association between current domperidone exposure and cardiac arrhythmia or sudden death." | 8.93 | Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. ( Holcombe, A; Leelakanok, N; Schweizer, ML, 2016) |
" This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population." | 7.96 | Risk of domperidone induced severe ventricular arrhythmia. ( Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG, 2020) |
"The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period." | 7.83 | The association between domperidone and ventricular arrhythmia in the postpartum period. ( Hanley, GE; Mintzes, B; Morgan, SG; Oberlander, TF; Smolina, K, 2016) |
"The results of two large epidemiological studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom." | 7.83 | Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. ( , 2016) |
"Recent evidence suggested that oral form of domperidone may possess pro-arrhythmic effects and increase the risk of ventricular arrhythmia." | 7.81 | Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. ( Chen, HL; Hsiao, FY, 2015) |
"Domperidone, a "hidden" neuroleptic, is used for symptomatic treatment of gastroesophageal reflux disease, despite its uncertain efficacy." | 7.78 | Domperidone: ventricular arrhythmia and sudden death (continued). ( , 2012) |
"Domperidone is a prokinetic agent widely prescribed in adults and children with gastrointestinal disorders." | 6.46 | Domperidone and long QT syndrome. ( Giorgi, G; Rossi, M, 2010) |
"Severe cardiac arrhythmias occurred in two patients." | 5.27 | Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. ( Hamer, J; Hunter, RW; Osborne, RJ; Slevin, ML, 1985) |
"We systematically searched MEDLINE, PubMed, EMBASE, Scopus and CINAHL Plus to identify observational studies examining the association of domperidone and sudden cardiac death and/or ventricular arrhythmia." | 5.12 | Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. ( Douros, A; Filion, KB; Moriello, C; Ou, LB, 2021) |
" From these publications, it cannot be concluded that domperidone exposure definitely increases the risk of "sudden cardiac death", "death associated with ventricular arrhythmia" or "ventricular arrhythmia" The most concrete result of these studies is that the risk is higher with metoclopramide exposure compared to domperidone exposure." | 5.01 | Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone. ( Tuğlular, I; Yüksel, K, 2019) |
"The first author performed EMBASE, PubMed and Scopus searches to identify human studies assessing the association between current domperidone exposure and cardiac arrhythmia or sudden death." | 4.93 | Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. ( Holcombe, A; Leelakanok, N; Schweizer, ML, 2016) |
"To evaluate the risk of QT prolongation, ventricular arrhythmias and sudden cardiac death associated with the use of oral domperidone in adults without cancer." | 4.91 | [Cardiac adverse effects of domperidone in adult patients: a systematic review]. ( Avila, A; Caraballo, L; Marzi, M; Molina, G; Piskulic, L; Weitz, D, 2015) |
" Reports of QT prolongation, ventricular arrhythmias and SCD were located (predominantly high/very high-dose IV domperidone)." | 4.91 | Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. ( Buffery, PJ; Strother, RM, 2015) |
" This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population." | 3.96 | Risk of domperidone induced severe ventricular arrhythmia. ( Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG, 2020) |
"Risk-minimization measures (RMM), including label revisions were implemented in Europe for domperidone because of evidence of increased incidence of cardiac arrhythmia and sudden cardiac death." | 3.91 | Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. ( Fife, D; Hu, P; Kaplan, S; Oliveria, SA; Phillips, S; Richarz, U; Waller, J, 2019) |
"Observational retrospective studies have linked domperidone and prolonged QT interval, ventricular arrhythmias and risk of sudden death." | 3.85 | [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database]. ( Auffret, M; Béné, J; Gautier, S; Rochoy, M, 2017) |
"The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period." | 3.83 | The association between domperidone and ventricular arrhythmia in the postpartum period. ( Hanley, GE; Mintzes, B; Morgan, SG; Oberlander, TF; Smolina, K, 2016) |
"The results of two large epidemiological studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom." | 3.83 | Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. ( , 2016) |
" In 2012, Health Canada released a warning regarding domperidone use, based on associations with life-threatening arrhythmias and death." | 3.83 | Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study. ( Al-Dabbagh, R; Cooray, M; Forbes, N; Liu, LW; Tse, F; Xenodemetropoulos, T; Yuan, Y, 2016) |
"Recent evidence suggested that oral form of domperidone may possess pro-arrhythmic effects and increase the risk of ventricular arrhythmia." | 3.81 | Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. ( Chen, HL; Hsiao, FY, 2015) |
"Domperidone, a "hidden" neuroleptic, is used for symptomatic treatment of gastroesophageal reflux disease, despite its uncertain efficacy." | 3.78 | Domperidone: ventricular arrhythmia and sudden death (continued). ( , 2012) |
" In the second case, QT interval prolongation occurred in a patient taking quetiapine and citalopram, and whose use of hydrocholorothiazide and history of chronic alcohol abuse likely contributed by rendering the patient hypokalemic." | 3.76 | Multifactorial QT interval prolongation. ( Baranchuk, A; Digby, G; Machaalany, J; Malik, P; Methot, M; Redfearn, D; Simpson, CS, 2010) |
"To determine whether oral domperidone is associated with QT interval prolongation and ventricular arrhythmia and to identify factors that can influence these effects." | 3.74 | Effect of domperidone on QT interval in neonates. ( Djeddi, D; Kongolo, G; Lefaix, C; Léké, A; Mounard, J, 2008) |
"Several cases of QT prolongation and ventricular tachyarrhythmia have been reported with domperidone, a gastrokinetic and antiemetic agent available worldwide but still under investigation in the United States." | 3.70 | Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. ( Cardinal, R; Daleau, P; Drolet, B; Rousseau, G; Turgeon, J, 2000) |
"The risk of sudden cardiac death (SCD) can be increased with the use of drugs." | 3.01 | Drug-induced Sudden Death: A Scoping Review. ( Amaro-Hosey, K; Blanco-Silvente, L; Capellà, D; Castells, X; Loma-Osorio, P, 2023) |
"To assess the steady-state pharmacokinetic and QT(c) effects of domperidone and ketoconazole, given alone and together." | 2.77 | Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. ( Baisley, KJ; Boyce, MJ; Warrington, SJ, 2012) |
"Domperidone is a proposed treatment of orthostatic hypotension (OH) in Parkinson's disease (PD)." | 2.55 | Domperidone for Hypotension in Parkinson's Disease: A Systematic Review. ( Bacchi, S; Chim, I; Kramer, P; Postuma, RB, 2017) |
"Domperidone is a prokinetic agent widely prescribed in adults and children with gastrointestinal disorders." | 2.46 | Domperidone and long QT syndrome. ( Giorgi, G; Rossi, M, 2010) |
"The risk of serious ventricular arrhythmias (SVA) in clinical practice in China has not been investigated." | 1.56 | Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China. ( Jiang, K; Liang, W; Qiu, H; Shu, M; Wu, K; Zhang, D; Zhang, Y, 2020) |
"The phenomenon of sudden cardiac death is usually related to the worsening of existing heart conditions leading to ventricular arrhythmia (VA)." | 1.42 | A case of sudden cardiac death following Domperidone self-medication. ( De Leo, D; Fais, P; Gottardo, R; Laposata, C; Lockwood, R; Vermiglio, E, 2015) |
"There have been reports of cardiac arrest in older patients associated with domperidone." | 1.27 | Continuous ECG monitoring of children with cancer receiving domperidone. ( Campbell, RW; Craft, AW; Hunter, AS; Nobbs, J; Pritchard-Jones, K; Ratcliffe, JM, 1986) |
"Severe cardiac arrhythmias occurred in two patients." | 1.27 | Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. ( Hamer, J; Hunter, RW; Osborne, RJ; Slevin, ML, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (11.11) | 29.6817 |
2010's | 24 (66.67) | 24.3611 |
2020's | 4 (11.11) | 2.80 |
Authors | Studies |
---|---|
Amaro-Hosey, K | 1 |
Castells, X | 1 |
Blanco-Silvente, L | 1 |
Loma-Osorio, P | 1 |
Capellà, D | 1 |
Zhang, Y | 1 |
Shu, M | 1 |
Liang, W | 1 |
Jiang, K | 1 |
Zhang, D | 1 |
Qiu, H | 1 |
Wu, K | 1 |
Song, BG | 1 |
Lee, YC | 1 |
Min, YW | 1 |
Kim, K | 1 |
Lee, H | 1 |
Son, HJ | 1 |
Rhee, PL | 1 |
Ou, LB | 1 |
Moriello, C | 1 |
Douros, A | 1 |
Filion, KB | 1 |
Frommeyer, G | 2 |
Fischer, C | 2 |
Ellermann, C | 2 |
Dechering, DG | 2 |
Kochhäuser, S | 2 |
Lange, PS | 2 |
Wasmer, K | 1 |
Fehr, M | 2 |
Eckardt, L | 2 |
Grzeskowiak, LE | 2 |
Smithers, LG | 1 |
Smolina, K | 2 |
Morgan, S | 1 |
Mintzes, B | 2 |
Hanley, G | 1 |
Oberlander, T | 1 |
Bacchi, S | 1 |
Chim, I | 1 |
Kramer, P | 1 |
Postuma, RB | 1 |
Yüksel, K | 1 |
Tuğlular, I | 1 |
Fife, D | 2 |
Waller, J | 1 |
Kaplan, S | 1 |
Hu, P | 1 |
Phillips, S | 1 |
Oliveria, SA | 1 |
Richarz, U | 1 |
Amir, LH | 1 |
Caraballo, L | 2 |
Molina, G | 2 |
Weitz, D | 2 |
Piskulic, L | 2 |
Avila, A | 2 |
Marzi, M | 2 |
Chen, HL | 1 |
Hsiao, FY | 1 |
Buffery, PJ | 1 |
Strother, RM | 1 |
Fais, P | 1 |
Vermiglio, E | 1 |
Laposata, C | 1 |
Lockwood, R | 1 |
Gottardo, R | 1 |
De Leo, D | 1 |
Leelakanok, N | 1 |
Holcombe, A | 1 |
Schweizer, ML | 1 |
Hanley, GE | 1 |
Oberlander, TF | 1 |
Morgan, SG | 1 |
Forbes, N | 1 |
Cooray, M | 1 |
Al-Dabbagh, R | 1 |
Yuan, Y | 1 |
Tse, F | 1 |
Liu, LW | 1 |
Xenodemetropoulos, T | 1 |
Rochoy, M | 1 |
Auffret, M | 1 |
Béné, J | 1 |
Gautier, S | 1 |
Djeddi, D | 1 |
Kongolo, G | 1 |
Lefaix, C | 1 |
Mounard, J | 1 |
Léké, A | 1 |
Hennessy, S | 1 |
Leonard, CE | 1 |
Palumbo, CM | 1 |
Bilker, WB | 1 |
Newcomb, C | 1 |
Kimmel, SE | 1 |
Rossi, M | 1 |
Giorgi, G | 1 |
Digby, G | 1 |
Machaalany, J | 1 |
Malik, P | 1 |
Methot, M | 1 |
Simpson, CS | 1 |
Redfearn, D | 1 |
Baranchuk, A | 1 |
Johannes, CB | 1 |
Varas-Lorenzo, C | 1 |
McQuay, LJ | 1 |
Midkiff, KD | 1 |
Boyce, MJ | 1 |
Baisley, KJ | 1 |
Warrington, SJ | 1 |
Bozzo, P | 1 |
Koren, G | 1 |
Ito, S | 1 |
Drolet, B | 1 |
Rousseau, G | 1 |
Daleau, P | 1 |
Cardinal, R | 1 |
Turgeon, J | 1 |
Osborne, RJ | 2 |
Slevin, ML | 2 |
Hunter, RW | 2 |
Hamer, J | 2 |
Quinn, N | 1 |
Parkes, D | 1 |
Jackson, G | 1 |
Upward, J | 1 |
Ratcliffe, JM | 1 |
Nobbs, J | 1 |
Campbell, RW | 1 |
Hunter, AS | 1 |
Pritchard-Jones, K | 1 |
Craft, AW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized Clinical Trial: Use of Domperidone to Increase Milk Production in Mothers With Newborns Hospitalized in Neonatology[NCT03221855] | Early Phase 1 | 30 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
9 reviews available for domperidone and Arrhythmias, Cardiac
Article | Year |
---|---|
Drug-induced Sudden Death: A Scoping Review.
Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Humans; Risk Factor | 2023 |
Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
Topics: Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Death, Sudden, Cardiac; Domperidone; Humans; | 2021 |
Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.
Topics: Animals; Arrhythmias, Cardiac; Databases, Bibliographic; Death, Sudden, Cardiac; Domperidone; Dopami | 2017 |
Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone.
Topics: Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Humans; Metoclopramide; Risk | 2019 |
[Proarrhythmic effects of domperidone in infants: a systematic review].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cisapride; Contraindications; Cytochrome P-450 CYP3A; Dom | 2014 |
[Cardiac adverse effects of domperidone in adult patients: a systematic review].
Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastroesophag | 2015 |
Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudde | 2015 |
Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Case-Control | 2016 |
Domperidone and long QT syndrome.
Topics: Adult; Animals; Arrhythmias, Cardiac; Child; Death, Sudden, Cardiac; Domperidone; Dopamine Antagonis | 2010 |
1 trial available for domperidone and Arrhythmias, Cardiac
Article | Year |
---|---|
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study.
Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Analysis of Variance; Area Under Curve; Arrhythm | 2012 |
26 other studies available for domperidone and Arrhythmias, Cardiac
Article | Year |
---|---|
Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China.
Topics: Administration, Oral; Adult; Antiemetics; Arrhythmias, Cardiac; China; Databases, Factual; Domperido | 2020 |
Risk of domperidone induced severe ventricular arrhythmia.
Topics: Adolescent; Adult; Aged; Antiemetics; Arrhythmias, Cardiac; Benzamides; Benzyl Compounds; Child; Chi | 2020 |
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Domperidone; Drug Interactions; Erythromycin; Fema | 2018 |
Use of domperidone and risk of ventricular arrhythmia in the postpartum period: getting to the heart of the matter.
Topics: Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Humans; Postpartum Period | 2017 |
Response to "use of domperidone and risk of ventricular arrhythmia in the postpartum period: Getting to the heart of the matter".
Topics: Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Humans; Postpartum Period | 2017 |
Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
Topics: Antiemetics; Arrhythmias, Cardiac; Clinical Decision-Making; Death, Sudden, Cardiac; Domperidone; Do | 2016 |
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe.
Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Cross-Sectional Studies | 2019 |
Pharmacological management of low milk supply with domperidone: separating fact from fiction.
Topics: Age Factors; Arrhythmias, Cardiac; Breast Feeding; Death, Sudden, Cardiac; Domperidone; Dopamine Ant | 2014 |
Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Co | 2015 |
A case of sudden cardiac death following Domperidone self-medication.
Topics: Alcoholism; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastrointestinal Agen | 2015 |
The association between domperidone and ventricular arrhythmia in the postpartum period.
Topics: Adult; Arrhythmias, Cardiac; British Columbia; Cohort Studies; Domperidone; Dopamine Antagonists; Fe | 2016 |
Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperido | 2016 |
[Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Car | 2017 |
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone.
Topics: Animals; Antiemetics; Arrhythmias, Cardiac; Domperidone; Dose-Response Relationship, Drug; Female; O | 2017 |
Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
Topics: Antiemetics; Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Humans; Long QT Synd | 2008 |
Effect of domperidone on QT interval in neonates.
Topics: Administration, Oral; Arrhythmias, Cardiac; Domperidone; Dopamine Antagonists; Drug-Related Side Eff | 2008 |
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database.
Topics: Arrhythmias, Cardiac; Cisapride; Cohort Studies; Databases, Factual; Death, Sudden, Cardiac; Domperi | 2008 |
Multifactorial QT interval prolongation.
Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohex | 2010 |
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Contro | 2010 |
Domperidone: ventricular arrhythmia and sudden death (continued).
Topics: Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Death, Sudden; Domperidone; Female; Gastroesophage | 2012 |
Health Canada advisory on domperidone should I avoid prescribing domperidone to women to increase milk production [corrected]?
Topics: Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Female; Galactogogues; Humans; La | 2012 |
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders.
Topics: Action Potentials; Animals; Antiemetics; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cation Tr | 2000 |
Cardiotoxicity of intravenous domperidone.
Topics: Arrhythmias, Cardiac; Domperidone; Female; Humans; Infusions, Parenteral; Vomiting | 1985 |
Cardiotoxicity of domperidone.
Topics: Aged; Arrhythmias, Cardiac; Domperidone; Heart; Humans; Male | 1985 |
Continuous ECG monitoring of children with cancer receiving domperidone.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Child | 1986 |
Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Cisplat | 1985 |